Understanding different types of type 2 diabetes in diverse populations
Metabolomic and genomic expansion of type 2 diabetes subtyping in multiethnic populations
This study is looking at how type 2 diabetes can be different for people from various backgrounds by exploring genetic and metabolic factors, so we can find better ways to treat and manage the condition for everyone.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10975140 on NIH RePORTER |
What this research studies
This research aims to identify and classify different subtypes of type 2 diabetes (T2D) by examining genetic and metabolic factors across various ethnic groups. By analyzing data from multiple studies, the project seeks to understand how T2D manifests differently in individuals, which can help tailor treatment strategies to improve patient outcomes. The research will focus on integrating diverse data types to uncover the physiological drivers behind T2D complications and responses to treatment. Ultimately, this work aims to enhance clinical decision-making for managing T2D.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with type 2 diabetes, particularly those from diverse racial and ethnic backgrounds.
Not a fit: Patients who do not have type 2 diabetes or those outside the age range of 21 years and older may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for individuals with type 2 diabetes.
How similar studies have performed: Previous research has shown promise in subclassifying type 2 diabetes, but this study aims to expand on those findings by including a more diverse population, making it a novel approach.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Bancks, Michael Patrick — Wake Forest University Health Sciences
- Study coordinator: Bancks, Michael Patrick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.